Idroalkalika is a supplement of Magnesium, Potassium, Alkali in the form of citrates tribasici of the last generation, and also provides two powerful antioxidants, anti-aging, such as Carnosine and Taurine.
Idroalkalika is absolutely free of Apsartame, Acesulfame K and sugar, and provides little more than 3 Kcal/ envelope.
This unique product was created to facilitate the hydration and inviting to drink more thanks to the delicious taste of almond, which gives it water to drink. Hydration has always been difficult today becomes easy and very enjoyable thanks to Idroalkalika: hydration and intelligent.
Magnesium and Potassium in alkaline form are the form most usable by the body and is more similar while the Carnosine and Taurine are substances with anti-aging and antioxidants that are very powerful.
Why settle to give water to the aroma-free of values or to take exorbitant amounts of Aspartame and Acesulfame K, the safety of which is very fallacious for the same Science, when we can idratarci, integrating salts and protecting our body?
*VNR = the Nutritional Values of Reference
INGREDIENTS: Potassium Citrate, Magnesium Citrate, Isomalt (educolarante), Flavouring, Xanthan Gum ( gelling agent) ,Sucralose (sweetener), Taurine, Caramel, Carnosine, Colloidal Silica (anti-caking agent).
Dosage: it Is recommended to take 1 sachet per day, dissolve in 1.5 Liters of water.
WARNINGS: do Not exceed the recommended daily dose. Keep out of the reach of children under three years of age. Supplements should not be in-thesis as a substitute for a varied and balanced diet and a healthy lifestyle. Store in a cool and dry place away from sources of light and heat. The expiry date refers to the product in the package in-tegra, and properly stored. Alkalika Mg is contraindicated in patients with hyperkalemia or ipermagnesemia, or by conditions that may predispose to the appearance of such alterations in plasma. These conditions include chronic renal failure, uncontrolled diabetes mellitus. The contemporary intake of Alkalika Mg and potassium-sparing drugs (triamterene, spironolactone, amiloride) may de-terminate hyperkalemia. Therefore, it is recommended to monitor the performance of the kaliemia. There are no known interactions with other drugs.